Consultation on the Medical Services Advisory Committee (MSAC) Revised Draft Guidelines

Closed 12 Oct 2020

Opened 31 Aug 2020


The Medical Services Advisory Committee (MSAC) is an independent scientific committee, established by the Minister for Health in 1998. The committee comprises individuals with expertise in clinical medicine, health economics and consumer matters.

MSAC evaluates medical services, health technologies and health programs proposed for public funding, in order to advise the Minister for Health on whether a medical service, health technology or program should be publicly funded, and the circumstances under which it should be funded.

Supported by the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC), MSAC assesses applications on their comparative safety, clinical effectiveness and cost effectiveness, and total cost, using best available evidence

The MSAC Guidelines (Therapeutic Guidelines and Investigative Guidelines) for preparing Assessment Reports for MSAC (and their associated Assessment Report templates), provide practical information on how to present evidence to MSAC and its sub-committees.

These Guidelines are also used by other stakeholders (including health technology assessment groups, the medical profession, industry, clinical and patient groups, and the general community), as a source of information.

The Guidelines promote processes that work to ensure Australians have access to safe, clinically effective and cost-effective medical services, health technologies and health programs.

A review of the MSAC Guidelines (the Review) has commenced, to ensure assessment processes are aligned with best practice in health technology assessment of therapeutic and investigative medical technologies and services.

The Review is looking at current versions of the Therapeutic Guidelines (Version 2.0; March 2016) and Investigative Guidelines (Version 3.0; July 2017), and addressing technical method issues in these Guidelines (that have been raised by MSAC and its stakeholders since the last substantial revision).

An updated version of the Guidelines will provide guidance for newer technologies, including genetic testing for heritable diseases and other screening tests. 

An external contractor, Adelaide Health Technology Assessment (AHTA), has been tasked to review and develop the updated (draft) Guidelines, for consultation.

A Guidelines Review Steering Committee has been established, in order to provide strategic oversight.

In addition, a Technical Reference Group has been established, to provide technical oversight and advice to both the Steering Committee and external contractor (AHTA) during development and finalisation of the updated Guidelines.

Why we are consulting

The Department is interested in obtaining views and feedback from the general public and future users on the updated MSAC Guidelines. The Department recognises the importance of consulting for the long-term success of the revised Guidelines. Your input is essential to this process and you are encouraged to provide submissions via this portal or send an email to

Submissions must be relevant to the proposed amendments. In addition, submissions may include information on:

  • Suggested improvements.
  • Whether or not you support the changes, including suggestions for alternatives.
  • An assessment of how any of the changes might impact on you.

Please find below the Draft MSAC Guidelines, for which we are seeking consultation.

If you wish to download the document, please click on the double arrows '>>' and then download.

Your browser does not support inline PDF viewing.Please download the PDF.

Draft MSAC Guidelines - Word version

What happens next

The Department thanks you for your submission. All submissions received will be reviewed. Unless marked confidential or indicated otherwise in the submission form (see Privacy information), submissions may be made available on the MSAC Guidelines Review website.

Any queries relating to submissions should be directed to by email to:


  • Introduction to MSAC Webinar

    From 27 Aug 2020 at 15:00 to 27 Aug 2020 at 16:00

    For more information, please visit and click on the Guidelines Review Tab along the top banner.

  • MSAC Guidelines Review Consumer Briefing

    From 10 Sep 2020 at 11:00 to 10 Sep 2020 at 12:00

    For more information, please visit and click on the Guidelines Review Tab along the top banner.

  • MSAC Guidelines Review Technical User Briefing

    From 17 Sep 2020 at 11:00 to 17 Sep 2020 at 12:00

    For more information, please visit and click on the Guidelines Review Tab along the top banner.


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Health professionals
  • General public
  • Community groups
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biogicals
  • Other


  • Health technology
  • Medicare
  • Health insurance